CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-21 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −74,500 | $24.27 | $1.8M | 28,475 |
| 2025-07-21 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −74,500 | 5,292,917 | ||
| 2025-07-18 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +400 | 28,747 | ||
| 2025-07-18 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −400 | $24.01 | $10K | 28,347 |
| 2025-07-18 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −400 | 3,506,865 | ||
| 2025-07-18 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +500 | 28,975 | ||
| 2025-07-18 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −500 | $24.01 | $12K | 28,475 |
| 2025-07-18 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −500 | 5,367,417 | ||
| 2025-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +50,000 | 78,475 | ||
| 2025-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −50,000 | $22.04 | $1.1M | 28,475 |
| 2025-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −50,000 | 5,367,917 | ||
| 2025-06-10 | Moon Youngme E Director | Grant or award | +12,020 | 65,889 | ||
| 2025-06-10 | Briggs Teresa Director | Grant or award | +12,020 | 50,879 | ||
| 2025-06-10 | WILLIAMS RONALD A Director | Grant or award | +17,362 | 100,623 | ||
| 2025-06-10 | Raider Jeffrey Jacob Director | Grant or award | +12,020 | 508,485 | ||
| 2025-06-10 | SINGER BRADLEY E Director | Grant or award | +16,026 | 31,819 | ||
| 2025-06-10 | Hunt Andrew Director | Grant or award | +16,026 | 1,929,231 | ||
| 2025-06-03 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise | +9,816 | 33,905 | ||
| 2025-06-03 | Gilboa David Abraham Co-Chief Executive Officer | Shares withheld for taxes | −5,430 | $21.48 | $117K | 28,475 |
| 2025-06-03 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −44,640 | 566,256 |
Page 12 of 20 · 390 trades